Results 61 to 70 of about 3,331,814 (239)
Ischemic stroke is one of the leading causes of severe disability and death. In clinical settings, tissue plasminogen activator (t-PA) for thrombolytic therapy is the only globally approved drug for the treatment of ischemic stroke.
T. Fukuta+3 more
semanticscholar +1 more source
Melatonin Pharmacokinetics Following Oral Administration in Preterm Neonates
Melatonin possesses potential efficacy in perinatal brain injuries, and has been proposed as adjunctive pharmacological therapy in combination with hypothermia in the clinical setting.
Silvia Carloni+8 more
doaj +1 more source
Piracetam in Postconcussion Syndrome: preliminary results of a randomised study using SPECT [PDF]
Aim of this study was to study the changes in regional cerebral perfusion following administration of the drug piracetam using single photon emission computed tomography (SPECT) in patients with postconcussion syndrome (PCS).
Deepak Agrawal, NK Gowda
doaj
The use of Thiocetam in the complex therapy of combat-related brain contusion
Each patient presents a unique set of characteristics and challenges when it comes to acute cerebral ischemia resulting from craniocerebral injury.
I. F. Bielenichev+6 more
doaj +1 more source
Sulfur-containing secondary metabolites as neuroprotective agents.
Sulfur containing secondary metabolites are a relatively small group of substances of plant origin. The present review is focused on their neuroprotective properties. The results obtained in a series of in vitro and in vivo studies are reported.
A. Venditti, A. Bianco
semanticscholar +1 more source
Neuroprotective Strategies for Ischemic Stroke—Future Perspectives
Ischemic stroke is the main cause of death and the most common cause of acquired physical disability worldwide. Recent demographic changes increase the relevance of stroke and its sequelae.
Matteo Haupt+3 more
semanticscholar +1 more source
Kynurenic acid (KYNA), a putative neuroprotective agent, modulates glutamatergic pathways in schizophrenia and Parkinson’s disease but is limited by acute motor activity impairments (e.g., ataxia).
Diána Martos+4 more
doaj +1 more source
3,5-Diaryl-4,5-dihydroisoxazoles were synthesized and evaluated as monoamine oxidase (MAO) enzyme inhibitors and iron chelators. All compounds exhibited selective inhibitory activity towards the B isoform of MAO in the nanomolar concentration range.
Rita Meleddu+11 more
doaj +1 more source
Background and Objectives: Autoimmune inflammation of the central nervous system followed by myelin destruction, oxidative stress, and reduced neuroprotective factors play key roles in the pathogenesis of multiple sclerosis (MS). S-allyl cysteine (SAC),
Hossein Zeinali+2 more
doaj
Zinc ionophores as neuroprotective agents [PDF]
Zinc ionophores, molecules that carry zinc ions across the cell membrane, can decrease apoptosis in animals subjected to experimental heart attack, brain injury, neurodegeneration, and epilepsy. Here we show that zinc ionophores at low μg/kg BW doses have neuroprotective effects in three different stroke models in rodents: focal ischemia models (middle
Natalia V. Gulyaeva+4 more
openaire +2 more sources